Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CFO Jeffrey Thomas Elliott sold 1,888 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $61.43, for a total value of $115,979.84. Following the completion of the transaction, the chief financial officer now […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) Director D Scott Coward sold 1,376 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $61.43, for a total value of $84,527.68. Following the completion of the transaction, the director now directly owns […]
Rhenman & Partners Asset Management AB trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 8.6% in the third quarter, Holdings Channel.com reports. The firm owned 160,000 shares of the medical research company’s stock after selling 15,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Exact Sciences were […]
Akumin (NASDAQ:AKUMQ – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares Akumin and Exact […]
Biondo Investment Advisors LLC increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 112,696 shares of the medical research company’s stock after buying an additional 3,103 shares […]